HMGB1 and neoplasm: Inflammation, including tumor-related inflammation, is the main factor contributing to the release of HMGB1; however, the release of HMGB1 from tumor cells themselves may also contribute to the high plasma concentration of HMGB1 in the tumor-bearing state [21].